25.38USD-0.26%Mkt Cap: —P/E: 25.36Last update: 2026-06-01
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty paymen…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap—
Enterprise Value377.94M USD
Revenue (TTM)48.55M USD
Gross Profit48.09M USD
Net Income (TTM)31.71M USD
Revenue/Share4.025 USD
Last Price25.38 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees14
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)25.36
P/E (Forward)—
PEG—
EV/EBITDA45.56
EV/Revenue7.78
P/S—
P/B3.60
EPS (TTM)1.00
EPS (Forward)—
52W Range
25.145% of range30.00
52W High30.00 USD
52W Low25.14 USD
Profitability
Gross Margin99.04%
Oper. Margin-3.90%
EBITDA Margin17.08%
Profit Margin271.97%
ROE37.78%
ROA11.63%
Growth
Revenue Growth-22.60%
Earnings Growth207.90%
Cash Flow & Leverage
Operating CF2.87M USD
CapEx (TTM)20.73M USD
FCF Margin-26.92%
FCF Yield—
Net Debt38.64M USD
Net Debt/EBITDA4.66
Balance Sheet
Debt/Equity1.57
Current Ratio3.59
Quick Ratio3.31
Book Value/Sh7.074 USD
Cash/Share6.865 USD
Dividends
Fwd Div Rate2.160 USD
Trail. Div Rate0.0000 USD
Div. Yield8.47%
5Y Avg Yield8.23%
Payout Ratio—
Ex-Div DateApr 2, 2026
Pay DateApr 15, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float914.87K
Insiders0.00%
Institutions1.02%
Short Interest
Short Ratio0.1d
Shares Short122
Short (prev mo.)1.57K
Technical
SMA 5025.74 (-1.4%)
SMA 20026.17 (-3.0%)
Beta0.90
S&P 52W Chg27.70%
Avg Vol (30d)3.52K
Avg Vol (10d)1.70K
Technical Indicators
RSI (14)48.2
MACD-0.0879
MACD Signal-0.1289
MACD Hist.+0.0410
BB Upper25.51 USD
BB Middle25.34 USD
BB Lower25.17 USD
BB Width1.33%
ATR (14)0.1518 USD
Vol Ratio (20d)0.64x